Your browser doesn't support javascript.
Anti-COVID-19 vaccination coverage in a group of obstetrician gynecologists from Venezuela
Gaceta Medica de Caracas ; 130:S450-S458, 2022.
Artigo em Espanhol | Scopus | ID: covidwho-1995012
ABSTRACT

Objectives:

Determining Anti-COVID-19 vaccination range in a group of Venezuelan obstetrician-gynecologists, specifying the type of vaccine received, according to the vaccination schedule, symptomatology, and level of pathology mild, moderate, or severe. M ethod Descriptive and cross-sectional study in 173 Venezuelan obstetrician-gynecologists, members of WhatsApp group. The information was collected by WhatsApp, through a survey consisting of five questions did you receive a COVID-19 vaccine? If you received it, what type of vaccine did you get? Please indicate dose dates. Have you been diagnosticated with COVID-19? If you had the disease, on what date did you make the diagnosis? were you treated at home? Did you require hospitalization or warrant ICU?

Results:

The majority of respondents were vaccinated (82.08 %);one group has not done so (9.82 %) and another has yet to complete its vaccination schedule (8.09 %). Seven types of vaccines were applied Sinopharm - Vero Cell (69.71 %), Sputnik V (20.42 %), Pfizer (4.92 %), Johnson and Johnson (2.11 %), Moderna (1.40 %), Sinovac (0.70 %) and one respondent received a mixed vaccination schedule AstraZeneca in its first dose and Pfizer in the second (0.70 %). 30.05 % of respondents admitted to having suffered from COVID-19, there were two reinfections (3.86 %). One of them, three months after receiving the second dose of Sputnik V, the other reinfection was in an unvaccinated respondent. Forty-one of the fifty-four cases occurred in unvaccinated people (75.92 %), eight were post-vaccinated (15.81 %) between three and twelve weeks after the second dose, and five with incomplete vaccination schedules (9.25 %). There were eight severe cases (14.81 %), four unvaccinated (50 %), three with an incomplete vaccination schedule (37.5 %), and one post-vaccinated (12.5 %), infected three weeks after completing their vaccination schedule with Simopharm - Vero Cell. Three obstetrician-gynecologist doctors died (5.55 % lethality), and none completed their respective vaccination schedules.

Conclusions:

Doctors and the entire health team are at high risk of contagion when caring for patients. Vaccination coverage of this personnel must be total. © 2022 Academia Nacional de Medicina. All rights reserved.
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: Scopus Tópicos: Vacinas País/Região como assunto: América do Sul / Venezuela Idioma: Espanhol Revista: Gaceta Medica de Caracas Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: Scopus Tópicos: Vacinas País/Região como assunto: América do Sul / Venezuela Idioma: Espanhol Revista: Gaceta Medica de Caracas Ano de publicação: 2022 Tipo de documento: Artigo